Are you Dr. Klekotka?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
Suite 5b
Saint Louis, MO 63110Phone+1 314-362-2643Fax+1 314-454-5626
Summary
- Dr. Paul Klekotka, MD is a board certified dermatologist in Saint Louis, Missouri. He is currently licensed to practice medicine in California.
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 2003 - 2006
- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2002 - 2003
- Washington University in St. Louis School of MedicineClass of 2002
Certifications & Licensure
- CA State Medical License 2010 - 2026
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- Immune Checkpoint Agonists for Inflammatory Skin Diseases.Matthew D Vesely, Paul F Lizzul, Paul Klekotka, Nicole Joller, Adam Raff
The Journal of Investigative Dermatology. 2025-02-08 - Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2.Sydney I Ramirez, Paul G Lopez, Farhoud Faraji, Urvi M Parikh, Amy Heaps
JCI Insight. 2024-12-20 - 1 citationsSARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback.Nathaniel Bloom, Sydney I Ramirez, Hallie Cohn, Urvi M Parikh, Amy Heaps
The Journal of Infectious Diseases. 2024-11-15
Grant Support
- Role Of NK Cells In Contact HypersensitivityNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2009